BioVie Inc. Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest
BioVie Inc. (BIVI) had Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest of $19.01 million as of 2025-06-30, per its S-1/A filed 2026-08-06.
Financial Statements › Balance Sheet › Equity › Equity, Including Portion Attributable to Noncontrolling Interest
us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest · last filed 2026-08-06
- 2025-06-30: Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest $19.01M.
- 2024-06-30: Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest $15.51M.
- 2023-06-30: Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest $15.34M.
- 2022-12-31: Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest $26.07M.
| Period end | Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest | Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest as first filed |
|---|---|---|
| 2025-06-30 | $19.01M S-1/A · filed 2026-08-06 | |
| 2024-06-30 | $15.51M S-1/A · filed 2026-08-06 | |
| 2023-06-30 | $15.34M S-1/A · filed 2026-08-06 | |
| 2022-12-31 | $26.07M 10-Q · filed 2023-02-10 | |
| 2022-09-30 | $5.96M 10-Q · filed 2023-02-10 | |
| 2022-06-30 | $3.67M 10-Q · filed 2023-02-10 | |
| 2021-12-31 | $16.07M 10-Q · filed 2023-02-10 | |
| 2021-09-30 | $20.23M 10-Q · filed 2023-02-10 | |
| 2021-06-30 | $5.05M 10-Q · filed 2023-02-10 | |
| 2021-03-31 | $11.40M 10-Q · filed 2021-05-10 | |
| 2020-12-31 | $13.07M 10-Q · filed 2021-05-10 | |
| 2020-09-30 | $14.60M 10-Q · filed 2021-05-10 | |
| 2020-06-30 | -$21.50M 10-Q · filed 2021-05-10 | |
| 2020-03-31 | -$2.34M 10-Q · filed 2021-05-10 | |
| 2019-12-31 | -$2.04M 10-Q · filed 2021-05-10 | |
| 2019-09-30 | -$8.72M 10-Q · filed 2021-05-10 | |
| 2019-06-30 | $2.13M 10-Q · filed 2021-05-10 | |
| 2019-03-31 | $2.79M 10-Q · filed 2020-05-13 | |
| 2018-12-31 | $3.54M 10-Q · filed 2020-05-13 | |
| 2018-09-30 | $4.02M 10-Q · filed 2020-05-13 | $4.02M 10-Q · filed 2018-11-14 |
| 2018-06-30 | $111.20K 10-K/A · filed 2020-08-07 | $111.20K 10-K · filed 2018-10-05 |
| 2018-03-31 | $555.44K 10-Q · filed 2019-05-10 | |
| 2017-12-31 | $791.07K 10-Q · filed 2019-05-10 | |
| 2017-09-30 | $1.08M 10-Q · filed 2019-05-10 | |
| 2017-06-30 | $1.16M 10-K · filed 2019-09-27 | $1.16M 10-K · filed 2018-10-05 |
| 2016-06-30 | $1.92M 10-K · filed 2018-10-05 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Aspire Biopharma Holdings, Inc. (ASBP) | United States | $0.012B | -0.60 |
| ADIAL PHARMACEUTICALS, INC. (ADIL) | United States | $0.012B | |
| Phio Pharmaceuticals Corp. (PHIO) | United States | $0.012B | -0.92 |
| Tempest Therapeutics, Inc. (TPST) | United States | $0.013B | |
| Scienture Holdings, Inc. (SCNX) | United States | $0.012B | -0.38 |
| KIORA PHARMACEUTICALS INC (KPRX) | United States | $0.012B | |
| Dare Bioscience, Inc. (DARE) | United States | $0.011B | |
| AEON Biopharma, Inc. (AEON) | United States | $0.013B | -0.36 |
| MUSTANG BIO, INC. (MBIO) | United States | $0.013B | |
| Vistagen Therapeutics, Inc. (VTGN) | United States | $0.013B | -0.14 |